JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 491.35 million compared to INR 630.94 million a year ago. Revenue was INR 520.76 million compared to INR 673.28 million a year ago. Net loss was INR 33.06 million compared to INR 76.32 million a year ago. Basic loss per share from continuing operations was INR 0.42 compared to INR 0.62 a year ago. Diluted loss per share from continuing operations was INR 0.42 compared to INR 0.62 a year ago.